[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_1125 

# __Reduced viral load on surfaces__

## Stakeholders benefitting from this Benefit

* [healthcare workers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_68.md)
* [patients](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_31.md)
* [public and healthcare settings](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_440.md)

## Name of the Benefit

Decreased risk of exposure to high viral loads on frequently touched surfaces

## Description of Benefits pertaining to Beneficiaries

* [Private investors investing in surface disinfectants would benefit from improved asset value (e.g. increased demand for disinfectant products)](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_1255.md)
* [Improved infection control and reduced transmission risk](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_1418.md)

## Articles mentionning this Benefit

* [Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_264.md)
* [Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_233.md)

